International immunopharmacology
Dihydromyricetin improves DSS-induced colitis and behavioral disorders by regulating the microbiota-gut-brain axis balance and inhibiting the activation of NLRP3 inflammasome.
Guyi Cong, Di Ao, Xuelian Mei, Rui Zhao, Rui Guo, Xiquan Ke, Zhenzeng Ma, Lin Gu, Hailun Zheng
Published: 202610.1016/j.intimp.2026.116237
Abstract
Patients with inflammatory bowel disease (IBD) commonly exhibit psychiatric symptoms, such as anxiety and depression. However, studies on drugs addressing the concurrent amelioration of these symptoms in this patient population are rare. Previous stu…
Preview only. Read the full abstract at the source